Why Pfizer Stock Slumped on Friday
Investors were cautiously pessimistic about the latest news coming out of the company's lab.In the thick of the coronavirus pandemic several years ago, any positive news from a developer of COVID-19 vaccines or drugs would have been met with a surge of buying in its stock. We're not in 2021 anymore, though, and an encouraging development from Pfizer (PFE -1.43%) on a combination COVID/influenza jab was met with a collective shrug by the market. In fact, investors traded out of the stock to the point that it ...